Gufic Biosciences cash flow

Latest FY26

Cash from operations: ₹45.0cr−63.3% on FY25
Capital spending: ₹31.2cr−58.7% on FY25
Free cash flow: ₹13.8cr−70.7% on FY25
Cash from financing: ₹32.5cr−₹37.2 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	30.8	21.1	17.0	22.3
	—	35.5	23.1	15.4	—
	—	−1.5	−1.5	−1.4	−0.7
	—	−0.0	0.0	−0.0	−0.0
	—	0.0	0.0	2.3	—
	—	−0.1	0.4	0.3	—
	—	−108	−16.4	−17.0	−67.9
	—	−23.6	7.4	−153	−55.3
	—	0.6	0.0	0.0	—
	—	36.3	16.6	40.0	−12.0
	—	0.0	0.6	0.6	—
Cash from operating activities
	99.3	86.5	94.1	116	—
	—	−29.7	51.2	−96.1	—
	—	56.8	145	19.6	—
	—	11.8	22.8	27.0	27.7
	—	45.0	123	−7.5	−26.6
Cash from investing activities
	—	31.2	75.5	113	—
	—	0.0	4.8	4.6	—
	—	0.0	0.0	1.0	—
	—	0.1	−0.0	0.0	—
	—	0.0	0.0	0.0	—
	—	1.0	0.9	1.0	1.0
	—	−0.7	−1.0	5.7	—
	—	−31.0	−70.8	−102	−191
Cash from financing activities
	—	0.3	0.0	100.0	—
	—	100	16.8	42.3	143
	—	25.5	23.5	36.8	—
	—	8.6	8.6	6.9	6.6
	—	—	—	2.1	—
	—	32.8	20.9	12.6	6.6
	—	1.0	1.0	1.0	—
	—	−0.2	0.0	−0.6	—
	—	32.5	−37.2	82.4	234
	—	46.5	14.6	−27.5	—
	—	46.5	14.6	−27.5	17.0
	—	—	—	1.1	—
Reference items
	165	151	135	146	—
	16.8%	16.0%	16.4%	18.1%	—
	13.8	13.8	47.0	−120	−26.6
	—	55.8	19.5	−6.4	—
	₹1.37	₹1.37	₹4.69	−₹11.98	−₹2.65
	308.23×	—	—	—	—
	—	0.70×	1.76×	−0.09×	—
	—	11.8	22.8	27.0	27.7
	—	32.8	20.9	12.6	6.6

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

GUFICBIO₹423.75

Gufic Biosciences Limited

· Pharma & Health

₹ CrorePeersRPGLIFE UNICHEMLAB GUJTHEM ORCHPHARMA SMSPHARMA INDSWFTLAB FDC IOLCPMcap ₹4,249 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	22.3	17.0	21.1	30.8	—
+ Finance Costs	—	15.4	23.1	35.5	—
+ Interest Income	-0.7	-1.4	-1.5	-1.5	—
+ Dividend Income	-0.0	-0.0	0.0	-0.0	—
+ Other Non-cash Items	—	2.3	0.0	0.0	—
+ Other Reconciling Items	—	0.3	0.4	-0.1	—
Changes in Working Capital
+ Inventories	-67.9	-17.0	-16.4	-107.6	—
+ Trade Receivables — Current	-55.3	-153.2	7.4	-23.6	—
+ Other Financial Assets — Non-current	—	0.0	0.0	0.6	—
+ Trade Payables — Current	-12.0	40.0	16.6	36.3	—
+ Other Financial Liabilities — Non-current	—	0.6	0.6	0.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	—	115.7	94.1	86.5	99.3
+ Total Adjustments (incl. Working Capital)	—	-96.1	51.2	-29.7	—
Cash from Operations (pre-tax)	—	19.6	145.4	56.8	—
+ Income Taxes Paid	27.7	27.0	22.8	11.8	—
Cash from Operating Activities	-26.6	-7.5	122.6	45.0	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	—	112.7	75.5	31.2	—
+ Disp of Fixed Assets	—	4.6	4.8	0.0	—
+ Purchase of Investments (Equity / Debt)	—	1.0	0.0	0.0	—
+ Acq of Subsidiaries / Businesses (net)	—	0.0	-0.0	0.1	—
+ Dividends Received — Investing	—	0.0	0.0	0.0	—
+ Interest Received — Investing	1.0	1.0	0.9	1.0	—
+ Other Inflows / (Outflows) — Investing	—	5.7	-1.0	-0.7	—
Cash from Investing Activities	-190.7	-102.4	-70.8	-31.0	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	—	100.0	0.0	0.3	—
+ Proceeds from Borrowings	142.6	42.3	16.8	100.3	—
+ Repayment of Borrowings	—	36.8	23.5	25.5	—
+ Payment of Lease Liabilities	6.6	6.9	8.6	8.6	—
+ Payment of Finance Lease Liabilities	—	2.1	—	—	—
+ Interest Paid	6.6	12.6	20.9	32.8	—
+ Dividends Paid	—	1.0	1.0	1.0	—
+ Other Inflows / (Outflows) — Financing	—	-0.6	0.0	-0.2	—
Cash from Financing Activities	234.3	82.4	-37.2	32.5	—
Net Changes in Cash (pre-FX)	—	-27.5	14.6	46.5	—
Net Changes in Cash	17.0	-27.5	14.6	46.5	—
Closing Cash	—	1.1	—	—	—
Reference Items
EBITDA	—	145.9	134.7	151.3	164.6
EBITDA Margin %	—	18.08	16.43	16.03	16.78
Free Cash Flow (CFO − Capex)	-26.6	-120.2	47.0	13.8	13.8
Free Cash Flow to Equity	—	-6.4	19.5	55.8	—
Free Cash Flow per Basic Share	-2.65	-11.98	4.69	1.37	1.37
Price to Free Cash Flow	—	—	—	—	308.23
Cash Flow to Net Income	—	-0.09	1.76	0.70	—
Cash Paid for Taxes	27.7	27.0	22.8	11.8	—
Cash Paid for Interest	6.6	12.6	20.9	32.8	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.